187 related articles for article (PubMed ID: 9367070)
1. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
Levine N; Moon TE; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):957-61. PubMed ID: 9367070
[TBL] [Abstract][Full Text] [Related]
2. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
Moon TE; Levine N; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):949-56. PubMed ID: 9367069
[TBL] [Abstract][Full Text] [Related]
3. Design and recruitment for retinoid skin cancer prevention (SKICAP) trials. The Southwest Skin Cancer Prevention Study Group.
Moon TE; Levine N; Cartmel B; Bangert J; Rodney S; Schreiber M; Peng YM; Ritenbaugh C; Meyskens F; Alberts D
Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):661-9. PubMed ID: 8547834
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
[TBL] [Abstract][Full Text] [Related]
5. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
6. Dose response of retinol and isotretinoin in the prevention of nonmelanoma skin cancer recurrence.
Clouser MC; Roe DJ; Foote JA; Harris RB; Alberts DS
Nutr Cancer; 2010; 62(8):1058-66. PubMed ID: 21058193
[TBL] [Abstract][Full Text] [Related]
7. Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.
Richtig E; Soyer HP; Posch M; Mossbacher U; Bauer P; Teban L; Svolba G; Wolf IH; Fritsch P; Zelger B; Volc-Platzer B; Gebhart W; Mischer P; Steiner A; Pachinger W; Hintner H; Gschnait F; Rappersberger K; Pilarski P; Pehamberger H;
J Clin Oncol; 2005 Dec; 23(34):8655-63. PubMed ID: 16260701
[TBL] [Abstract][Full Text] [Related]
8. Clinical and laboratory adverse effects associated with long-term, low-dose isotretinoin: incidence and risk factors. The Isotretinoin-Basal Cell Carcinomas Study Group.
Tangrea JA; Adrianza E; Helsel WE; Taylor PR; Hartman AM; Peck GL; Edwards BK
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):375-80. PubMed ID: 8348061
[TBL] [Abstract][Full Text] [Related]
9. Cancer protection in xeroderma pigmentosum variant (XP-V).
Somos S; Farkas B; Schneider I
Anticancer Res; 1999; 19(3B):2195-9. PubMed ID: 10472330
[TBL] [Abstract][Full Text] [Related]
10. Facial resurfacing for nonmelanoma skin cancer prophylaxis.
Hantash BM; Stewart DB; Cooper ZA; Rehmus WE; Koch RJ; Swetter SM
Arch Dermatol; 2006 Aug; 142(8):976-82. PubMed ID: 16924046
[TBL] [Abstract][Full Text] [Related]
11. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.
Clark LC; Combs GF; Turnbull BW; Slate EH; Chalker DK; Chow J; Davis LS; Glover RA; Graham GF; Gross EG; Krongrad A; Lesher JL; Park HK; Sanders BB; Smith CL; Taylor JR
JAMA; 1996 Dec; 276(24):1957-63. PubMed ID: 8971064
[TBL] [Abstract][Full Text] [Related]
12. Serum carotenoids and alpha-tocopherol and risk of nonmelanoma skin cancer.
Dorgan JF; Boakye NA; Fears TR; Schleicher RL; Helsel W; Anderson C; Robinson J; Guin JD; Lessin S; Ratnasinghe LD; Tangrea JA
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1276-82. PubMed ID: 15298946
[TBL] [Abstract][Full Text] [Related]
13. Oral isotretinoin in the treatment and prevention of cutaneous squamous cell carcinoma.
Jones E; Korzenko A; Kriegel D
J Drugs Dermatol; 2004; 3(5):498-502. PubMed ID: 15552602
[TBL] [Abstract][Full Text] [Related]
14. A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group.
Greenberg ER; Baron JA; Stukel TA; Stevens MM; Mandel JS; Spencer SK; Elias PM; Lowe N; Nierenberg DW; Bayrd G
N Engl J Med; 1990 Sep; 323(12):789-95. PubMed ID: 2202901
[TBL] [Abstract][Full Text] [Related]
15. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
[TBL] [Abstract][Full Text] [Related]
16. High sun protection factor sunscreens in the suppression of actinic neoplasia.
Naylor MF; Boyd A; Smith DW; Cameron GS; Hubbard D; Neldner KH
Arch Dermatol; 1995 Feb; 131(2):170-5. PubMed ID: 7857113
[TBL] [Abstract][Full Text] [Related]
17. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use.
van der Pols JC; Williams GM; Pandeya N; Logan V; Green AC
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2546-8. PubMed ID: 17132769
[TBL] [Abstract][Full Text] [Related]
18. [Medical treatment of epitheliomas].
Revenga Arranz F
Rev Clin Esp; 1997 Dec; 197(12):841-6. PubMed ID: 9477677
[No Abstract] [Full Text] [Related]
19. Patients' perceptions on participation in a cancer chemoprevention trial.
Tangrea JA; Adrianza ME; Helsel WE
Cancer Epidemiol Biomarkers Prev; 1992; 1(4):325-30. PubMed ID: 1303133
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.
Elmets CA; Viner JL; Pentland AP; Cantrell W; Lin HY; Bailey H; Kang S; Linden KG; Heffernan M; Duvic M; Richmond E; Elewski BE; Umar A; Bell W; Gordon GB
J Natl Cancer Inst; 2010 Dec; 102(24):1835-44. PubMed ID: 21115882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
